Parkman Healthcare Partners LLC Acumen Pharmaceuticals, Inc. Transaction History

Parkman Healthcare Partners LLC

  • $708 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$2.97 - $4.64 $79,714 - $124,537
-26,840 Reduced 4.45%
576,657 $2.34 Million
Q4 2023

Feb 14, 2024
BUY
$1.86 - $4.48 $192,850 - $464,499
103,683 Added 20.74%
603,497 $2.32 Million
Q3 2023

Nov 14, 2023
BUY
$4.15 - $9.72 $2.07 Million - $4.86 Million
499,814 New
499,814 $2.07 Million

Others Institutions Holding ABOS

# of Institutions
78
Shares Held
41.8M
Call Options Held
57.7K
Put Options Held
749K
View Full List

About Acumen Pharmaceuticals, Inc.

ABOS Quotes by TradingView
  • Ticker ABOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,503,100
  • Market Cap $72.5M
  • Description
  • Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...
More about ABOS
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email